The estimated Net Worth of Howard Horn is at least $8.75 Million dollars as of 23 February 2023. Mr. Horn owns over 2,248 units of Vir Biotechnology Inc stock worth over $1,806,475 and over the last 5 years he sold VIR stock worth over $4,727,292. In addition, he makes $2,213,940 as Chief Financial Officer and Secretary at Vir Biotechnology Inc.
Howard has made over 8 trades of the Vir Biotechnology Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 2,248 units of VIR stock worth $58,381 on 23 February 2023.
The largest trade he's ever made was selling 30,000 units of Vir Biotechnology Inc stock on 13 July 2020 worth over $1,501,800. On average, Howard trades about 7,648 units every 71 days since 2019. As of 23 February 2023 he still owns at least 230,712 units of Vir Biotechnology Inc stock.
You can see the complete history of Mr. Horn stock trades at the bottom of the page.
Howard Horn serves as Chief Financial Officer, Secretary of the Company. Prior to joining us, Mr. Horn served Biogen as its Vice President, Business Planning from June 2015 to October 2016, where he led Biogen’s resource allocation processes across all functions and regions. From October 2013 to June 2015, Mr. Horn served as Biogen’s Vice President, Strategic Corporate Financing, where he led Biogen’s corporate capital allocation processes. Mr. Horn previously held positions of increasing responsibility as a consultant in the Pharmaceutical and Medical Products Practice at McKinsey & Company, from 2004 to 2013, and as an equity research analyst in the Life Sciences group at UBS Group AG, from 1999 to 2002. Mr. Horn received his B.A. in Economics from Princeton University and his M.B.A. from the Wharton School of the University of Pennsylvania.
As the Chief Financial Officer and Secretary of Vir Biotechnology Inc, the total compensation of Howard Horn at Vir Biotechnology Inc is $2,213,940. There are 1 executives at Vir Biotechnology Inc getting paid more, with George Scangos having the highest compensation of $3,944,610.
Howard Horn is 43, he's been the Chief Financial Officer and Secretary of Vir Biotechnology Inc since 2019. There are 23 older and no younger executives at Vir Biotechnology Inc. The oldest executive at Vir Biotechnology Inc is Phillip Sharp, 75, who is the Independent Director.
Howard's mailing address filed with the SEC is C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO, CA, 94949.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over $197,171,926 worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth $139,246,875 . The most active insiders traders include Norbert W Bischofberger, Endurance (Cayman) Ltd Sb I..., and Kristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of $478,115. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth $95,082.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: